|
Mitigating aberrant Cdk5 Activation in SMA – A Novel Therapeutic Strategy Targeting Mitochondrial Function
SHORT DESCRIPTION
A targeted strategy that mitigates aberrant Cdk5 activity to restore mitochondrial function and reduce motor neuron degeneration in SMA models.
INVENTORS
Yongchao Ma*
Northwestern University Feinberg School of Medicine, Department of Pediatrics
* Principal Investigator
NU Tech...
Published: 4/27/2026
|
Updated: 4/27/2026
|
Inventor(s):
Keywords(s): Adjunct therapy, Neurodegenerative disease, Neurologic disease, Neurology, Rare diseases, SMA - Spinal muscular atrophy, Targeted therapy, Therapeutics
Category(s): Life Sciences > Therapeutics
|